Clinical Trial

Bone Microstructure by Using HR-pQCT After Esophagectomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2023 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Esophagectomy is most curative treatment to esophageal cancer. However, osteoporosis , which is characterized by both the loss of bone mass and the deterioration of bone architecture, is a serious complication in the long course after surgery. The aim of the present study was to evaluate osteoporosis by using high-resolution peripheral quantitative computed tomography (HR-pQCT) in the long course after esophagectomy. At least 3 years should have elapsed since operation without recurrence of esophageal cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-02; most recent amendment 2023-04-21.
Trial Details
NCT Number NCT05812235
Lead Sponsor Nagasaki University
Conditions Osteoporosis, Sarcopenia, Esophageal Cancer
Enrollment 118 participants
Start Date 2023-05-25
Primary Completion 2026-03-01 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2023-04-24